Cargando…
Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway
The mechanisms of efficacy for fecal microbiota transplantation (FMT) in treating recurrent Clostridioides difficile infection (rCDI) remain poorly defined, with restored gut microbiota-bile acid interactions representing one possible explanation. Furthermore, the potential implications for host phy...
Autores principales: | Monaghan, Tanya, Mullish, Benjamin H, Patterson, Jordan, Wong, Gane KS, Marchesi, Julian R, Xu, Huiping, Jilani, Tahseen, Kao, Dina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546339/ https://www.ncbi.nlm.nih.gov/pubmed/30183484 http://dx.doi.org/10.1080/19490976.2018.1506667 |
Ejemplares similares
-
Changes in IgA-targeted microbiota following fecal transplantation for recurrent Clostridioides difficile infection
por: Huus, Kelsey E, et al.
Publicado: (2020) -
The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection
por: Mullish, Benjamin H., et al.
Publicado: (2021) -
Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites
por: Martinez-Gili, Laura, et al.
Publicado: (2020) -
A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory Clostridioides difficile Infection
por: Monaghan, Tanya M., et al.
Publicado: (2021) -
Insights into the Evolving Epidemiology of Clostridioides difficile Infection and Treatment: A Global Perspective
por: Liu, Crystal, et al.
Publicado: (2023)